Harbert Fund Advisors’s MaxCyte MXCT Stock Holding History

Harbert Fund Advisors’s Portfolio MXCT Stock Details MXCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-98,304	Closed	-$639K	–	53
2022 Q3	$639K	Hold	98,304	–	–	0.34%	42
2022 Q2	$465K	Hold	98,304	–	–	0.23%	45
2022 Q1	$687K	Hold	98,304	–	–	0.29%	37
2021 Q4	$1M	Sell	98,304 -626,552	-86%	-$6.73M	0.25%	37
2021 Q3	$8.85M	Buy	+724,856	New	+$10.9M	3.14%	12

Other funds holding MXCT

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BWLSA

Blue Water Life Science Advisors Larkspur, California $159M AUM 139.66% 1-Year Est. Return

Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Harbert Fund Advisors's MXCT Position: Q4 2022 in Review

Harbert Fund Advisors sold out of MaxCyte (MXCT) in Q4 2022, closing a stake of 98,304 shares — an estimated $639K sold.

Harbert Fund Advisors first reported a position in MXCT in Q3 2021 and held it in 5 quarters. The position peaked at $8.85M in Q3 2021. 104 funds tracked by Wall St. Rank hold MXCT as of Q4 2022.

Harbert Fund Advisors reported no remaining MaxCyte position as of Q4 2022 after selling out during the quarter.
Harbert Fund Advisors sold 98,304 MaxCyte shares in Q4 2022, an estimated $639K.
Harbert Fund Advisors first reported a position in MaxCyte in Q3 2021 and held it in 5 quarters.
Harbert Fund Advisors's MaxCyte position peaked at $8.85M in Q3 2021.
104 funds tracked by Wall St. Rank held MaxCyte as of Q4 2022.

Based on Harbert Fund Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.